Casey McGrath
Medical · Philadelphia, PANPI 1821632324
Payments from drug & device makers
Across 491 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AbbVie$1K
- Lilly USA, LLC$864
- Novo Nordisk$859
- AstraZeneca$760
- Pfizer$471
- plus $3K from 30 others
What the payments were for
- Food & beverage$8,94399%
- Education$751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 109 | $2,022 |
| AbbVie(2 entities) | 88 | $1,323 |
| Lilly USA, LLC | 42 | $864 |
| Novo Nordisk | 47 | $859 |
| AstraZeneca | 45 | $760 |
| Pfizer | 26 | $471 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $300 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $290 |
| Exact Sciences | 12 | $249 |
| Astellas Pharma US Inc | 7 | $228 |
| Boehringer Ingelheim | 9 | $196 |
| Bayer | 8 | $133 |
| Otsuka America Pharmaceutical, Inc. | 6 | $122 |
| Johnson & Johnson | 5 | $109 |
| Corcept Therapeutics | 3 | $106 |
| Teva Pharmaceuticals USA, Inc. | 6 | $104 |
| Smith+Nephew | 5 | $89 |
| Kowa Pharmaceuticals America, Inc. | 5 | $88 |
| Valinor Pharma, LLC | 4 | $75 |
| Xeris Pharmaceuticals, Inc. | 3 | $71 |
| Philips North America LLC | 5 | $68 |
| Lundbeck LLC | 2 | $61 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Amgen | 2 | $51 |
| Novartis | 3 | $50 |
| Mylan Specialty L.p. | 3 | $48 |
| Almatica Pharma LLC | 2 | $47 |
| E.r. Squibb & Sons, L.L.C. | 3 | $40 |
| Redhill Biopharma Inc. | 2 | $30 |
| Amarin Pharma, Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Gilead | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
| Athena Bioscience, LLC | 1 | $9 |
How this compares
$9,018 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 141 | $96,612 |
| OzempicSemaglutide | 76 | $84,707 |
| TrulicityDulaglutide | 73 | $74,860 |
| JanuviaSitagliptin Phosphate | 70 | $60,568 |
| EliquisApixaban | 45 | $52,808 |
| FarxigaDapagliflozin Propanediol | 75 | $46,907 |
| JardianceEmpagliflozin | 50 | $36,951 |
| LinzessLinaclotide | 34 | $32,336 |
| Breo ElliptaFluticasone/Vilanterol | 66 | $30,194 |
| TivicayDolutegravir Sodium | 11 | $24,376 |
| DescovyEmtricitabine/Tenofov Alafenam | 11 | $23,781 |
| XareltoRivaroxaban | 17 | $22,671 |
| EntrestoSacubitril/Valsartan | 19 | $16,392 |
| MyrbetriqMirabegron | 23 | $15,333 |
| MovantikNaloxegol Oxalate | 21 | $14,502 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $2,022 | $130,576218 claims |
| Novo NordiskOzempic, Rybelsus | $859 | $98,64591 claims |
| AstraZenecaFarxiga, Brilinta, Breztri Aerosphere, Symbicort | $760 | $76,783143 claims |
| Lilly USA, LLCTrulicity | $864 | $74,86073 claims |
| PfizerEliquis | $471 | $52,80845 claims |
| AbbVieLinzess, Restasis Multidose | $1,323 | $40,95847 claims |
| Boehringer IngelheimJardiance | $196 | $36,95150 claims |
| GileadDescovy | $17 | $23,78111 claims |
| Johnson & JohnsonXarelto | $109 | $22,67117 claims |
| NovartisEntresto | $50 | $16,39219 claims |
| Astellas Pharma US IncMyrbetriq | $228 | $15,33323 claims |
| Redhill Biopharma Inc.Movantik | $30 | $14,50221 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,594 medical providers in Pennsylvania.
Other medical in Philadelphia
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Sarah SmithPhiladelphia$65K
- Victoria WongPhiladelphia$51K
- Parth PatelPhiladelphia$46K
- Zachary LutzPhiladelphia$30K
- Hawah MusaPhiladelphia$13K
- Carl BlackPhiladelphia$13K
- Ashley BarratPhiladelphia$12K
- Jacqueline KernaghanSpringfield$427K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.